Thoracic Med Onc @HopkinsKimmel. PD Heme/Med Onc Fellowship. Here for the #lcsm & #MedEd. Tweets my own.
Baltimore, MD
Joined April 2011
- Tweets1.1K
- Following1.5K
- Followers1.7K
- Likes10.6K
Kristen A. Marrone, MD retweeted
Congratulations to the 46 @ConquerCancerFd Merit Award winners (@Arshi_Syal @yajur_arya) here at #ASCOQLTY26! Such a talented bunch of early career researchers pursuing breakthroughs for so many different types of cancer. 🎉
View the list of recipients: bit.ly/4k6vbJw
Kristen A. Marrone, MD retweeted
We join the oncology community in mourning the passing of Dr. Rachna T. Shroff, a renowned GI cancers expert and a dedicated ASCO volunteer. We are humbled by her dedication and strive to honor her legacy of commitment and altruism.
Read more: bit.ly/4e7jBKu
Kristen A. Marrone, MD retweeted
Join us in Washington, DC on Saturday, October 10 for #DCLung26 - a 1-day, comprehensive, @IASLC endorsed, multidisciplinary, discussion-based lung cancer CME update! From trainee to seasoned professional, MD to RN, local or not - something for everyone!
medstarhealth.org/dclung
Kristen A. Marrone, MD retweeted
#PancreaticCancer on cover of @CR_AACR.
New study from @hopkinskimmel on fibroblasts regulating cancer cell lineage state.
Cancer-Associated Fibroblasts Promote Epithelial–Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer
aacrjournals.org/cancerres/a…
Kristen A. Marrone, MD retweeted
Want to get caught up on the latest updates in thoracic cancers? Join us for #DCLung26 in Washington, DC on Saturday, October 10 where you can learn from Dr. @kamarroneMD who joins the discussion on the evolving arena of EGFRm NSCLC. Sign up today!
medstarhealth.org/dclung
Kristen A. Marrone, MD retweeted
We're proud to join 57 organizations urging Congress to oppose OMB's proposed grantmaking rule and protect the future of biomedical research.
Patients deserve science — not politics.
Read the letter: unitedforcures.org/omb-lette…
#CuresCantWait
Kristen A. Marrone, MD retweeted
T-5 days until the @IASLC Hot Topics Meeting on Immunotherapy Resistance in Dublin ☘️
Join us for 2 days of top-class learning at the famous @tcddublin. IASLC membership free for students & trainees
Register here 👉🏻ht26-iaslc.eventsair.site/re…
discount code 👉🏻15FORDE
Kristen A. Marrone, MD retweeted
We are celebrating our wonderful 3rd yr oncology fellows at graduation
Bittersweet to say goodbye... we will miss you
We are cheering you on for all that lies ahead
Kristen A. Marrone, MD retweeted
Dr. Tina Cascone outlines rationale & science behind neoadjuvant and perioperative immunotherapy for early stage NSCLC at #ASCO26. How do we isolate the value of the adjuvant component after pCR or non-pCR? How do we best escalate non-pCR? ADC? Vaccine? Insightful discussion. – at Chicago, IL
Kristen A. Marrone, MD retweeted
Happy #PrideMonth from Sesame Street! Join us in celebrating and uplifting the LGBTQIA+ members of our community. ❤️🧡💛💚💙💜
Kristen A. Marrone, MD retweeted
Great discussion of KRAS G12D drugs by @KCArbourMD ends by highlighting the @MSK_DeptOfMed KRAS team
Kristen A. Marrone, MD retweeted
Another banner year at ASCO for our fellowship, with six Young Investigator Awards awarded to our trainees. Congratulations to our outstanding fellows on this well-deserved recognition!
Kristen A. Marrone, MD retweeted
ALK-Vac + concurrent ALK TKI in advanced ALK+ NSCLC: safe/well tolerated & induced de novo immune responses to targeted resistance mutations. 93% responded to ≥1 antigen; 33% to all. Predominant Th17/Th17.1 CD4+ expansion.
Novel concept. Congratulations to authors!
#ASCO26
Kristen A. Marrone, MD retweeted
📘 LIBRETTO-432 — NEJM
nejm.org/doi/full/10.1056/NE…
📗 HARMONi-6 — The Lancet
thelancet.com/journals/lance…
📘 RASolute 302 — NEJM
nejm.org/doi/full/10.1056/NE…
📘 PROTEUS — NEJM
nejm.org/doi/full/10.1056/NE…
Kristen A. Marrone, MD retweeted
1stL in KRASG12Cmut NSCLC will be crowded and complex. Elisrasib, another KRASG12Coff inh, reported activityn in 1stL alone and combo with pembro. Next future: how to decide intensification? Based on PDL1, comut, brain met status🤯.Will not be easy!! To icity is a concern #ASCO26
Look at this @Hopkins_HemOnc alumni mentor in action! Way to go @DrArsenOsipov
Sargis Hovhannisyan from pancreas cancer research @DrHendifar @jgong15 group @CedarsSinai presenting our work on molecular signatures that define KRAS Variants and their associated clinical outcomes.
There's a new version of this post
Kristen A. Marrone, MD retweeted
IDEO Xchange: New Agents in #mNSCLC
Phase 3 data from OptiTROP-Lung05 presented at ASCO 26 showed a PFS benefit for Sac-TMT + pembro in PD-L1+ aNSCLC over pembro alone, with a trend toward OS benefit.
Where do you see Sac-TMT+pembro potentially fitting into the mNSCLC landscape for PD-L1+ aNSCLC?
Answer here: linkedin.com/posts/mnsclc-as…
Xchange your vote with Drs. @lungoncdoc @NarjustFlorezMD @HwakeleeMD @JuliaRotow @COlazagasti @IvyLorena_Md @marinagarassino @christine_lovly @LuisERaez1 @maraantonoff @IyengarPuneeth @AnaVManana @kamarroneMD @Noha_Soror @christinemphmd
Kristen A. Marrone, MD retweeted
IDEO Xchange: ALK+ mNSCLC
Updated data from the phase 3 #CROWN study presented at ASCO 26 showed a 7-year PFS of 55% in patients treated withlorlatinib, with the median not yet reached.
What is your current preferred 1L therapy for patients with ALK+#mNSCLC?
Answer here: linkedin.com/posts/crown-asc…
Xchange your vote with Drs. @lungoncdoc @NarjustFlorezMD @HwakeleeMD @JuliaRotow @COlazagasti @IvyLorena_Md @marinagarassino @christine_lovly @LuisERaez1 @maraantonoff @IyengarPuneeth @AnaVManana @kamarroneMD @Noha_Soror @christinemphmd
Kristen A. Marrone, MD retweeted
Vote at the IDEO Xchange: Managing Asymptomatic Brain Mets in #NSCLC
Phase 3 data from ASCO 26 showed upfront cranial RT reduced intracranial progression in patients with oncogene-driven NSCLC and asymptomatic brain mets but did not impact survival.
Do you expect these data to impact how asymptomatic brain mets are managed?
Vote here: linkedin.com/posts/nsclc-asc…
Join Drs. @lungoncdoc @NarjustFlorezMD @HwakeleeMD @JuliaRotow @COlazagasti @IvyLorena_Md @marinagarassino @christine_lovly @LuisERaez1 @maraantonoff @IyengarPuneeth @AnaVManana @kamarroneMD @Noha_Soror @christinemphmd
Kristen A. Marrone, MD retweeted
IDEO Xchange: Sequencing in ES-SCLC
What would be your preferred sequencing strategy for ES-SCLC (assuming all are available)?
Vote now: linkedin.com/posts/ideo-xcha…
Join Drs. @lungoncdoc @NarjustFlorezMD @HwakeleeMD @JuliaRotow @COlazagasti @IvyLorena_Md @marinagarassino @christine_lovly @LuisERaez1 @maraantonoff @IyengarPuneeth @AnaVManana @kamarroneMD @Noha_Soror @christinemphmd